SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
1. Faruqi & Faruqi investigates claims against HIMS for potential securities violations. 2. Investors may join a class action due to alleged misleading statements. 3. Novo Nordisk ended its partnership with HIMS, heavily impacting its stock. 4. Stock dropped 34.6% on news of partnership termination, indicating investor concern. 5. August 25, 2025, is the deadline for investors to seek lead plaintiff status.